Regarding cell cycle regulation, inactivation of cell cycle inhibitors such as p53, p21 and p27 released by cells in G1/S and G2/M phases can allow cancer cells to continue dividing in the presence of DNA damage or replication errors, a phenomenon that can lead to resistance of cancer cells to DNA-damaging drugs (Clay & Fox, 2021). This evidence concerns the gene TP53 and cancer.